Barclay Damon forms practice handling pharmacy matters

SYRACUSE, N.Y. — Barclay Damon, LLP says it has a multidisciplinary group of attorneys providing legal services across the pharmacy, pharmaceutical, and health-innovation industries. Its national pharmacy team builds on decades of experience advising retail, specialty, compounding, infusion, long-term care, and 340B pharmacies as well as wholesalers, manufacturers, investors, and startups into a nationally focused, industry-specific practice, the Syracuse–based law firm said in a Sept. 9 announcement.

“We’ve advised pharmacy clients through every stage of growth and challenge,” Linda Clark, co-chair of the law firm’s pharmacy team, said in the announcement. “This launch reflects Barclay Damon’s commitment to delivering coordinated, industry-specific counsel that helps our clients stay compliant, protect their businesses, and seize opportunities in a complex regulatory and contractual environment.” This group of attorneys has experience in key practice areas that include regulatory compliance and PBM enrollment, audits, investigations, and terminations. The practice areas also include government investigations and enforcement defense; licensing and operational strategy; corporate transactions, investments, and rollups; data security, HIPAA compliance, and digital health; intellectual property, trademarks, and tech licensing; employment, workforce strategy, and tax planning; and real estate and pharmacy-site development.

“Our attorneys don’t just know the law, we understand how pharmacy businesses actually operate,” Brad Gallagher, pharmacy team co-chair, said. “Whether we’re advising a startup or defending a multistate provider, our focus is always on delivering clarity, minimizing risk, and driving results.” The pharmacy attorneys provide legal counsel to individuals and entities across the entire supply chain. That includes retail, specialty, compounding, infusion, long-term care, and 340B pharmacies; pharmacy owners, executives, and licensed pharmacists; and wholesalers, distributors, and pharmaceutical manufacturers. They also provide legal counsel for private-equity firms and other strategic investors; health-care startups, digital health companies, and technology innovators; and consultants, vendors, and service providers supporting the pharmacy sector, the firm said. The pharmacy attorneys will deal with representative matters that include recovering reimbursements and reversing PBM (pharmacy benefit manager) terminations and enrollment denials, including through litigation and emergency injunctions. They’ll also defend clients in complex federal and state audits and investigations, including those led by the U.S. Department of Justice (DOJ); Drug Enforcement Agency (DEA); Office of the Inspector General, and Office of the Medicaid Inspector General. ​ The attorneys can additionally advise startups and innovators on tech licensing, HIPAA compliance, funding, and go-to-market strategies. With about 300 attorneys, Barclay Damon describes itself as a regional law firm that operates New York offices in Syracuse (headquarters), Albany, Buffalo. Rochester, and New York City; along with New Haven, Connecticut; Boston, Massachusetts; Washington, D.C.; and Toronto, Ontario.